SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001104659-21-009794
Filing Date
2021-02-01
Accepted
2021-02-01 09:15:46
Documents
4
Period of Report
2021-01-27
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K/A tm214840d1_8ka.htm 8-K/A 21998
2 EXHIBIT 3.1 tm214840d1_ex3-1.htm EX-3.1 1672
3 GRAPHIC image001.jpg GRAPHIC 226480
4 GRAPHIC image002.jpg GRAPHIC 67354
  Complete submission text file 0001104659-21-009794.txt   430186
Mailing Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850
Business Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850 (734) 332-7800
Synthetic Biologics, Inc. (Filer) CIK: 0000894158 (see all company filings)

IRS No.: 133808303 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-12584 | Film No.: 21574946
SIC: 2834 Pharmaceutical Preparations